<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="40009">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01674023</url>
  </required_header>
  <id_info>
    <org_study_id>No.518</org_study_id>
    <nct_id>NCT01674023</nct_id>
  </id_info>
  <brief_title>MicroRNA Expression Profile in Human Vitreous of Patients With Various Vitreoretinal Diseases Requiring Vitrectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyorin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyorin University</source>
  <oversight_info>
    <authority>Japan: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MicroRNAs are important regulators of many cellular functions but their expression profile
      in human vitreous is still unclear. Aim of this study is to investigate microRNA expression
      profile by PCR in human vitreous of patients with various vitreoretinal disorders and
      compare with that of patients with macular holes which are suggested to be similar to that
      of healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>MicroRNA expression profile in human vitreous investigated by PCR</measure>
    <time_frame>1month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>MicroRNA Expression Profile in Human Vitreous of Various Vitreoretinal Diseases</condition>
  <arm_group>
    <arm_group_label>human vitreous, human blood serum, PCR</arm_group_label>
    <description>human vitreous and blood serum sampling, PCR
1ml of human vitreous and 3ml of human blood serum of patients with various vitreoretinal diseases</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      3ml of blood serum and 1ml of vitreous
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pateints undergoing vitrectomy for various vitreoretinal disesases
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  any patients undergoing vitrectomy for various vitreoretinal diseases

        Exclusion Criteria:

          -  previously vitrectomized eyes
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hiroshi Keino, Assistant Proffesor</last_name>
    <email>keino@eye-center.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kazunari Hirota, MD</last_name>
    <email>hirota@eye-center.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kyorin University School Of Medicine</name>
      <address>
        <city>Mitakasi Sinkawa6-20-2</city>
        <state>Tokyo</state>
        <zip>181-8611</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiroshi Keino, Assistant Proffesor</last_name>
      <email>keino@eye-center.org</email>
    </contact>
    <contact_backup>
      <last_name>kazunari Hirota, MD</last_name>
      <email>hirota@eye-center.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>August 27, 2012</lastchanged_date>
  <firstreceived_date>August 23, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyorin University</investigator_affiliation>
    <investigator_full_name>Kazunari Hirota</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
